BusinessINSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle EastBy Nasdaq OMXMay 8, 2018, 8:02 PM UTC
BusinessCrownBio Demonstrates Advantages of Innovative Translational Oncology Platform in Scientific Posters at AACR 2018 MeetingBy Nasdaq OMXMay 8, 2018, 12:02 PM UTC
BusinessActinium Pharmaceuticals to Present at 19th Annual Bio€quity Europe Conference in Ghent, BelgiumBy Nasdaq OMXMay 8, 2018, 11:30 AM UTC
BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessInvivoscribe Submits Pre-Market Approval Application in Japan and Panel Track Supplement in the US to Screen Acute Myeloid Leukemia (AML) Patients for FLT3 MutationsBy Nasdaq OMXMay 8, 2018, 10:01 AM UTC
BusinessAptose Exercises Early Option for CG-806 License From CrystalGenomicsBy Nasdaq OMXMay 7, 2018, 11:01 AM UTC
BusinessCheck-Cap Announces Pricing of $17.5 Million Upsized Underwritten Public OfferingBy Nasdaq OMXMay 4, 2018, 1:15 PM UTC
BusinessCannabis Science Announces the Second Frontiers Peer-Reviewed Publication of its Research Results on the Use of Cannabinoids in the Treatment of CancersBy Nasdaq OMXMay 1, 2018, 11:44 AM UTC
